We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord

Ticker
SPL.AU

Price
0.10
Stock movement up
+0.00 (2.15%)
Company name
Starpharma Holdings Ltd
Exchange
(AU
,
Currency
AUD
)
Sector
Healthcare >
Biotechnology
Market cap
39.72M
Ent value
25.06M
Price/Sales
3.29
Price/Book
1.41
Div yield
-
Div growth
-
Growth years
-
FCF payout
-
Trailing P/E
-
Forward P/E
-
PEG
-
EPS growth
-10.61%
1 year return
-32.14%
3 year return
-52.56%
5 year return
-36.64%
10 year return
-15.30%
Last updated: 2025-04-05

DIVIDENDS

SPL.AU does not pay dividends or no data was received

VALUATION

Valuation Ratios

Loading...
Valuation Ratios data
Trailing P/E-
Price to OCF-
Price to FCF-
Price to EBITDA-
EV to EBITDA-

Valuation (Sales/Book Value)

Loading...
Valuation (Sales/Book Value) data
Price to Sales3.29
Price to Book1.41
EV to Sales2.07

FINANCIALS

Per share

Loading...
Per share data
Current share count418.11M
EPS (TTM)-0.05
FCF per share (TTM)-0.05

Income statement

Loading...
Income statement data
Revenue (TTM)12.08M
Gross profit (TTM)2.11M
Operating income (TTM)-34.47M
Net income (TTM)-19.21M
EPS (TTM)-0.05
EPS (1y forward)-

Margins

Loading...
Margins data
Gross margin (TTM)17.49%
Operating margin (TTM)-285.32%
Profit margin (TTM)-158.97%

Balance Sheet

Loading...
Please create a free account or log in to access this chart
Balance Sheet data
Cash23.36M
Net receivables6.34M
Total current assets32.92M
Goodwill0.00
Intangible assets0.00
Property, plant and equipment7.29M
Total assets36.81M
Accounts payable2.73M
Short/Current long term debt3.53M
Total current liabilities6.66M
Total liabilities8.70M
Shareholder's equity28.12M
Net tangible assets0.00

Cash flow

Loading...
Please create a free account or log in to access this chart
Cash flow data
Operating cash flow (TTM)-19.66M
Capital expenditures (TTM)324.50K
Free cash flow (TTM)-19.98M
Dividends paid (TTM)0.00

Financial returns

Loading...
Please create a free account or log in to access this chart
Financial returns data
Return on Equity-68.31%
Return on Assets-52.17%
Return on Invested Capital-64.70%
Cash Return on Invested Capital-67.31%

STOCK INFORMATION

Stock chart

Loading...
Stock price data
Open0.09
Daily high0.10
Daily low0.09
Daily Volume1.00M
All-time high2.49
1y analyst estimate0.95
Beta0.76
EPS (TTM)-0.05
Dividend per share-
Ex-div date-
Next earnings date-

Downside potential

Loading...
Downside potential data
SPL.AUS&P500
Current price drop from All-time high-96.18%-17.56%
Highest price drop-96.51%-56.47%
Date of highest drop27 Jun 20249 Mar 2009
Avg drop from high-48.52%-11.07%
Avg time to new high152 days12 days
Max time to new high2223 days1805 days
COMPANY DETAILS
SPL.AU (Starpharma Holdings Ltd) company logo
Marketcap
39.72M
Marketcap category
Small-cap
Description
Starpharma Holdings Limited, a biopharmaceutical company, engages in the research, development, and commercialization of dendrimer products for pharmaceutical, life science, and other applications worldwide. The company's products include VivaGel BV, a non-antibiotic vaginal gel for the treatment of bacterial vaginosis (BV) and prevention of recurrent BV; VIRALEZE, an antiviral nasal spray; and VivaGel condom, an antiviral condom coating. It is also involved in the development of dendrimer enhanced product (DEP) delivery platform, consisting of DEP SN38 for the treatment of ovarian and colorectal cancer that is in Phase II clinical trial; DEP cabazitaxel for prostate and ovarian cancer treatment that is in Phase II clinical trial; and DEP docetaxel to treat pancreatic and other cancers that is in Phase II clinical trial. In addition, the company is developing DEP HER2 radiodiagnostic and DEP HER2 ADC to treat solid tumors; SPL7013 for vaginal gel; and DEP HER2 radiodiagnostic. It has a collaboration agreement with Medicxi to develop petalion therapeutics, a novel cancer therapy using Starpharma's dendrimer technology. Starpharma Holdings Limited was incorporated in 1997 and is headquartered in Abbotsford, Australia.
Employees
40
Investor relations
-
CEO
Country
Australia
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
All newsPress releases
No items found